Triumph or tragedy: progress in cancer

Cancer is probably the number one research area among all human endeavors, receiving the largest portion of science funding in most countries. This is because cancer remains one of the oldest conundrums among all human maladies. Although we now have a greater understanding of the biological and molecular basis of cancer, its diagnosis and therapy still pose great challenges. In this review, our aim is not to establish a comprehensive understanding of cancer, which is essentially impossible, but to outline, in a more provocative way, why cancer research in the pursuit of a cure did not live up to its promise, as the death rate from cancer has not changed much after almost half a century. In addition, we discuss some future perspectives to give some insight into cancer research and debunk the old view that pouring money into cancer research is the only way to overcome this dreadful disease.

Anahtar Kelimeler:

Cancer, cancer research, cancer statistics, progress in cancer, cancer publications

Triumph or tragedy: progress in cancer

Keywords:

Cancer, cancer research, cancer statistics, progress in cancer, cancer publications,

PDF

___

Agrawal V, Alpini SEJ, Stone EM, Frenkel EP, Frankel AE (2012). Targeting methionine auxotrophy in cancer: discovery & exploration. Expert Opin Biol Th 12: 53–61.
Axelrod R, Axelrod DE, Pienta KJ (2006). Evolution of cooperation among tumor cells. P Natl Acad Sci USA 103: 13474–13479.
Baker NM, Der CJ (2013). Cancer: Drug for an ‘undruggable’ protein. Nature 497: 577–578.
Carlos RC, Dempsey AF, Patel DA, Dalton VK (2010). Cervical cancer prevention through human papillomavirus vaccination using the “teachable moment” for educational interventions. Obstet Gynecol 115: 834–838.
DeBerardinis RJ, Thompson CB (2012). Cellular metabolism and disease: what do metabolic outliers teach us? Cell 148: 1132– 1144.
Delage B, Fennell DA, Nicholson L, McNeish I, Lemoine NR, Crook T, Szlosarek PW (2010). Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer. Int J Cancer 126: 2762–2772.
Der CJ, Krontiris TG, Cooper GM (1982). Transforming genes of human bladder and lung-carcinoma cell-lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. P Natl Acad Sci 79: 3637–3640.
Eckhouse S, Lewison G, Sullivan R (2008). Trends in the global funding and activity of cancer research. Mol Oncol 2: 20–32.
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893–2917.
Ferrari M (2013). Slipping past cancer’s barriers. Am Sci 101: 430–433.
Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR (2004). A census of human cancer genes. Nat Rev Cancer 4: 177–183.
Geckil H, Gencer S, Uckun M (2004). Vitreoscilla hemoglobin expressing Enterobacter aerogenes and Pseudomonas aeruginosa respond differently to carbon catabolite and oxygen repression for production of L-asparaginase, an enzyme used in cancer therapy. Enzyme Microb Tech 35: 182–189.
Gerlinger M (2012). Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. New Engl J Med 367: 976– 976.
Greaves M, Maley CC (2012). Clonal evolution in cancer. Nature 481: 306–313.
Harvey JJ (1964). An unidentified virus which causes the rapid production of tumours in mice. Nature 204: 1104–1105.
Huang S (2013). Genetic and non-genetic instability in tumor progression: link between the fitness landscape and the epigenetic landscape of cancer cells. Cancer Metast Rev 32: 423–448.
International Cancer Genome Consortium, Hudson TJ, Anderson W, Artez A, Barker AD, Bell C, Bernabé RR, Bhan MK, Calvo F, Eerola I et al. (2010). International network of cancer genome projects. Nature 464: 993–998.
Jain RK (2014). An indirect way to tame cancer. Sci Am 310: 46–53.
Lawrence MS, Stojanov P, Mermel CH, Robinson JT, Garraway LA, Golub TR, Meyerson M, Gabriel SB, Lander ES, Getz G (2014). Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505: 495–501.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY et al. (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2095–2128.
Lu S, Chen GL, Ren CX, Kwabi-Addo B, Epner DE (2003). Methionine restriction selectively targets thymidylate synthase in prostate cancer cells. Biochem Pharmacol 66: 791–800.
Malumbres M, Barbacid M (2003). Timeline - RAS oncogenes: the first 30 years. Nat Rev Cancer 3: 459–465.
Maruyama R, Suzuki H, Yamamoto E, Imai K, Shinomura Y (2012). Emerging links between epigenetic alterations and dysregulation of noncoding RNAs in cancer. Tumor Biol 33: 277–285.
May M (2014). Attacking an epidemic. Nature 509: S50–S51.
Moore NM, Nagahara LA (2014). Physical biology in cancer. 1. Cellular physics of cancer metastasis. Am J Physiol-Cell Ph 306: C78–C79.
Muller HJ, Boos J (1998). Use of L-asparaginase in childhood ALL. Crit Rev Oncol Hemat 28: 97–113.
Parada LF, Tabin CJ, Shih C, Weinberg RA (1982). Human EJ bladder-carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature 297: 474–478.
Stewart BW, Wild CP, editors (2014). World Cancer Report. Geneva, Switzerland: WHO Press.
Swanton C (2012). Intratumor heterogeneity: evolution through space and time. Cancer Res 72: 4875–4882.
Timp W, Feinberg AP (2013). Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host. Nat Rev Cancer 13: 497–510.
US Senate (1971). US Senate Conquest of Cancer Act, 1971. Hearings before the Subcommittee on Health of the Committee on Labor and Public Welfare, United States Senate, 92nd Congress. Washington, DC, USA: US Senate, 1971.
Vogelstein B, Papadopoulos N, Velculescu VE, Zhou SB, Diaz LA, Kinzler KW (2013). Cancer genome landscapes. Science 339: 1546–1558.
von Stockar U, Liu JS (1999). Does microbial life always feed on negative entropy? Thermodynamic analysis of microbial growth. Biochim Biophys Acta 1412: 191–211.
Wirtz D, Konstantopoulos K, Searson PC (2011). The physics of cancer: the role of physical interactions and mechanical forces in metastasis. Nat Rev Cancer 11: 512–522.
World Economic Forum (2011). Global Risks. 6th ed. Geneva, Switzerland: World Economic Forum.
Yates LR, Campbell PJ (2012). Evolution of the cancer genome. Nat Rev Genet 13: 795–806.
Zhang QC, Austin RH (2012). Physics of cancer: the impact of heterogeneity. Annu Rev Conden Ma P 3: 363–382.